- Home
- CMP vs KOD Comparison
CMP vs KOD Comparison
Compare CMP & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMP
- KOD
- Stock Information
- Founded
- CMP 1993
- KOD 2009
- Country
- CMP United States
- KOD United States
- Employees
- CMP N/A
- KOD N/A
- Industry
- CMP Other Metals and Minerals
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CMP Basic Materials
- KOD Health Care
- Exchange
- CMP Nasdaq
- KOD Nasdaq
- Market Cap
- CMP 781.2M
- KOD 795.5M
- IPO Year
- CMP 2003
- KOD 2018
- Fundamental
- Price
- CMP $17.72
- KOD $20.87
- Analyst Decision
- CMP Hold
- KOD Buy
- Analyst Count
- CMP 3
- KOD 7
- Target Price
- CMP $20.00
- KOD $22.29
- AVG Volume (30 Days)
- CMP 367.9K
- KOD 774.7K
- Earning Date
- CMP 12-08-2025
- KOD 11-13-2025
- Dividend Yield
- CMP N/A
- KOD N/A
- EPS Growth
- CMP N/A
- KOD N/A
- EPS
- CMP N/A
- KOD N/A
- Revenue
- CMP $1,225,200,000.00
- KOD N/A
- Revenue This Year
- CMP $12.05
- KOD N/A
- Revenue Next Year
- CMP $4.15
- KOD N/A
- P/E Ratio
- CMP N/A
- KOD N/A
- Revenue Growth
- CMP 7.27
- KOD N/A
- 52 Week Low
- CMP $8.60
- KOD $1.92
- 52 Week High
- CMP $22.69
- KOD $22.14
- Technical
- Relative Strength Index (RSI)
- CMP 49.69
- KOD 61.84
- Support Level
- CMP $16.76
- KOD $18.15
- Resistance Level
- CMP $17.56
- KOD $22.14
- Average True Range (ATR)
- CMP 0.66
- KOD 1.83
- MACD
- CMP 0.05
- KOD -0.05
- Stochastic Oscillator
- CMP 52.56
- KOD 77.80
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.